Thubrikar Aortic Valve, Inc.
Our next-gen Transcatheter Aortic Valve Implantation (TAVI) device was designed after nature's valve and demonstrated preclinical superiority (Durability, etc.)
Dr. Mano Thubrikar designed Optimum TAV after the natural aortic valve to improve treatment for Severe Aortic Stenosis patients. Optimum TAV has surpassed 890 Million cycles (simulates > 24 years in vivo) in a durability test, and been successfully deployed by our delivery catheters in 16 animals. The Company expects additional clinical data from its licensees in Brazil and China in 2016 and 2017, respectively, and royalties thereafter.